Insights into the Reaction of Protein-tyrosine Phosphatase 1B
暂无分享,去创建一个
[1] M. Gresser,et al. Mechanism of Inhibition of Protein-tyrosine Phosphatases by Vanadate and Pervanadate* , 1997, The Journal of Biological Chemistry.
[2] M. Gresser,et al. Interaction of inorganic vanadate with glucose-6-phosphate dehydrogenase. Nonenzymic formation of glucose 6-vanadate. , 1985, The Journal of biological chemistry.
[3] D. Barford,et al. Visualization of the Cysteinyl-phosphate Intermediate of a Protein-tyrosine Phosphatase by X-ray Crystallography* , 1998, The Journal of Biological Chemistry.
[4] D. Herschlag,et al. Kinetic isotope effects for alkaline phosphatase reactions: implications for the role of active-site metal ions in catalysis. , 2007, Journal of the American Chemical Society.
[5] D. Barford,et al. Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. , 1995, Science.
[6] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[7] P G Drake,et al. Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains , 2001, Molecular and Cellular Biology.
[8] C. Hellberg,et al. Protein-tyrosine phosphatases and cancer , 2006, Nature Reviews Cancer.
[9] J. Morrow,et al. Altered transition state for the reaction of an RNA model catalyzed by a dinuclear zinc(II) catalyst. , 2008, Journal of the American Chemical Society.
[10] J. Kastrup,et al. Residue 182 influences the second step of protein-tyrosine phosphatase-mediated catalysis. , 2004, The Biochemical journal.
[11] A. Hengge. Isotope effects in the study of phosphoryl and sulfuryl transfer reactions. , 2002, Accounts of chemical research.
[12] S. Sprang,et al. Transition state structures and the roles of catalytic residues in GAP-facilitated GTPase of Ras as elucidated by (18)O kinetic isotope effects. , 2009, Biochemistry.
[13] M. Eberlin,et al. Intramolecular acid-base catalysis of a phosphate diester: modeling the ribonuclease mechanism. , 2008, Journal of the American Chemical Society.
[14] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[15] D. Herschlag,et al. Impaired transition state complementarity in the hydrolysis of O-arylphosphorothioates by protein-tyrosine phosphatases. , 1999, Biochemistry.
[16] Zhon-Yin Zhang,et al. Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development. , 2002, Annual review of pharmacology and toxicology.
[17] E. Fauman,et al. Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 Å and the complex with tungstate , 1994, Nature.
[18] Sheng Zhang,et al. PTP1B as a drug target: recent developments in PTP1B inhibitor discovery. , 2007, Drug discovery today.
[19] E. Fauman,et al. The X-ray Crystal Structures of Yersinia Tyrosine Phosphatase with Bound Tungstate and Nitrate , 1996, The Journal of Biological Chemistry.
[20] Jeffrey P. Jones,et al. Secondary 18O isotope effects for hexokinase-catalyzed phosphoryl transfer from ATP. , 1991, Biochemistry.
[21] D. Barford,et al. The structure and mechanism of protein phosphatases: insights into catalysis and regulation. , 1998, Annual review of biophysics and biomolecular structure.
[22] L. Iversen,et al. 2-(Oxalylamino)-Benzoic Acid Is a General, Competitive Inhibitor of Protein-tyrosine Phosphatases* , 2000, The Journal of Biological Chemistry.
[23] T. Hunter,et al. Signaling—2000 and Beyond , 2000, Cell.
[24] L. Wu,et al. Effects on general acid catalysis from mutations of the invariant tryptophan and arginine residues in the protein tyrosine phosphatase from Yersinia. , 2000, Biochemistry.
[25] Randy J Read,et al. Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .
[26] R. Wolfenden,et al. The rate of hydrolysis of phosphomonoester dianions and the exceptional catalytic proficiencies of protein and inositol phosphatases , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[27] A. Hengge,et al. Altered mechanisms of reactions of phosphate esters bridging a dinuclear metal center. , 2004, Journal of the American Chemical Society.
[28] D. Crans,et al. The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds. , 2004, Chemical reviews.
[29] E. Fauman,et al. A ligand‐induced conformational change in the yersinia protein tyrosine phosphatase , 1995, Protein science : a publication of the Protein Society.
[30] D S Lawrence,et al. Structural basis of plasticity in protein tyrosine phosphatase 1B substrate recognition. , 2000, Biochemistry.
[31] F. Haj,et al. Regulation of Receptor Tyrosine Kinase Signaling by Protein Tyrosine Phosphatase-1B* , 2003, The Journal of Biological Chemistry.
[32] Sean J. Johnson,et al. Impaired acid catalysis by mutation of a protein loop hinge residue in a YopH mutant revealed by crystal structures. , 2009, Journal of the American Chemical Society.
[33] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[34] Jack Snoeyink,et al. Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .
[35] Y. Zhao,et al. Reactivity of alcohols toward the phosphoenzyme intermediate in the protein-tyrosine phosphatase-catalyzed reaction: probing the transition state of the dephosphorylation step. , 1996, Biochemistry.
[36] J. Dixon,et al. Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. , 1991, The Journal of biological chemistry.
[37] D. Dunaway-Mariano,et al. The catalytic scaffold of the haloalkanoic acid dehalogenase enzyme superfamily acts as a mold for the trigonal bipyramidal transition state , 2008, Proceedings of the National Academy of Sciences.
[38] D. Lawrence,et al. Acquisition of a Specific and Potent PTP1B Inhibitor from a Novel Combinatorial Library and Screening Procedure* , 2001, The Journal of Biological Chemistry.
[39] D. Lawrence,et al. Probing the Molecular Basis for Potent and Selective Protein-tyrosine Phosphatase 1B Inhibition* , 2002, The Journal of Biological Chemistry.
[40] P. Nordlund,et al. Energetics of nucleophile activation in a protein tyrosine phosphatase. , 1997, Journal of molecular biology.
[41] L. Wu,et al. Probing the function of the conserved tryptophan in the flexible loop of the Yersinia protein-tyrosine phosphatase. , 2008, European journal of biochemistry.
[42] K. Peters,et al. Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery. , 2006, Acta crystallographica. Section D, Biological crystallography.
[43] A. Hengge,et al. CONCERTED OR STEPWISE MECHANISMS FOR ACYL TRANSFER REACTIONS OF P-NITROPHENYL ACETATE ? TRANSITION STATE STRUCTURES FROM ISOTOPE EFFECTS , 1994 .
[44] J. Denu,et al. Molecular Reactions of Protein PhosphatasesInsights from Structure and Chemistry , 2001 .
[45] J. Goodman,et al. Intramolecular general acid catalysis of phosphate transfer. nucleophilic attack by oxyanions on the PO3 2- group. , 2005, Journal of the American Chemical Society.
[46] D. Barford,et al. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. , 2000, Molecular cell.
[47] B. Finlay,et al. Phosphatases and kinases delivered to the host cell by bacterial pathogens. , 2000, Trends in microbiology.
[48] D. Barford,et al. Crystal structure of a complex between protein tyrosine phosphatase 1B and the insulin receptor tyrosine kinase. , 2005, Structure.
[49] N. Reiner,et al. Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1. , 2005, Clinical immunology.
[50] B. Kennedy,et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.
[51] J. Åqvist,et al. Computational modeling of the rate limiting step in low molecular weight protein tyrosine phosphatase , 1999, FEBS letters.
[52] L. Wu,et al. Nature of the transition state of the protein-tyrosine phosphatase-catalyzed reaction. , 1995, Biochemistry.
[53] L. Wu,et al. Examination of the transition state of the low-molecular mass small tyrosine phosphatase 1. Comparisons with other protein phosphatases. , 1997, Biochemistry.
[54] Joanna M. Sasin,et al. Protein Tyrosine Phosphatases in the Human Genome , 2004, Cell.
[55] D. Barford,et al. Crystal structure of human protein tyrosine phosphatase 1B. , 1994, Science.
[56] Jay Painter,et al. Electronic Reprint Biological Crystallography Optimal Description of a Protein Structure in Terms of Multiple Groups Undergoing Tls Motion Biological Crystallography Optimal Description of a Protein Structure in Terms of Multiple Groups Undergoing Tls Motion , 2005 .
[57] D. Barford,et al. Purification and crystallization of the catalytic domain of human protein tyrosine phosphatase 1B expressed in Escherichia coli. , 1994, Journal of molecular biology.
[58] T. Burke,et al. High-resolution structure of the Yersinia pestis protein tyrosine phosphatase YopH in complex with a phosphotyrosyl mimetic-containing hexapeptide. , 2003, Biochemistry.
[59] H. Waldmann,et al. Inhibitors of protein tyrosine phosphatases: next-generation drugs? , 2005, Angewandte Chemie.
[60] J. Ermolieff,et al. Protein tyrosine phosphatase 1B inhibitors for diabetes , 2002, Nature Reviews Drug Discovery.
[61] J. Dixon,et al. Active site labeling of the Yersinia protein tyrosine phosphatase: the determination of the pKa of the active site cysteine and the function of the conserved histidine 402. , 1993, Biochemistry.
[62] Peter Briggs,et al. A graphical user interface to the CCP4 program suite. , 2003, Acta crystallographica. Section D, Biological crystallography.
[63] J. Kastrup,et al. Water-molecule network and active-site flexibility of apo protein tyrosine phosphatase 1B. , 2004, Acta crystallographica. Section D, Biological crystallography.
[64] D. Bashford,et al. Density functional study of the mechanism of a tyrosine phosphatase: I. Intermediate formation. , 2002, Journal of the American Chemical Society.
[65] J. Dixon,et al. Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[66] V. J. Shiner. Reaction Rates of Isotopic Molecules , 1981 .
[67] M. Zhou,et al. Crystal structure of bovine low molecular weight phosphotyrosyl phosphatase complexed with the transition state analog vanadate. , 1997, Biochemistry.
[68] Jiali Gao,et al. Walden-Inversion-Enforced Transition-State Stabilization in a Protein Tyrosine Phosphatase , 1998 .
[69] W. Huskey. Isotope Effects in Chemistry and Biology , 2006 .
[70] J. Baell,et al. Phosphate isosteres in medicinal chemistry. , 2005, Current medicinal chemistry.
[71] Richard L. Pederson,et al. Reversible and in situ formation of organic arsenates and vanadates as organic phosphate mimics in enzymatic reactions: mechanistic investigation of aldol reactions and synthetic applications , 1989 .
[72] Z. Zhang,et al. Protein-tyrosine phosphatases: biological function, structural characteristics, and mechanism of catalysis. , 1998, Critical reviews in biochemistry and molecular biology.
[73] W. Hol,et al. The power of vanadate in crystallographic investigations of phosphoryl transfer enzymes , 2004, FEBS letters.
[74] Collaborative Computational,et al. The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.
[75] F. Hollfelder,et al. A Trojan horse transition state analogue generated by MgF3− formation in an enzyme active site , 2006, Proceedings of the National Academy of Sciences.
[76] R. Schowen,et al. Transition States of Biochemical Processes , 1978, Springer US.